SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decent increase of about 28.28% in the sales to Rs. 14327.50 millions was observed for the quarter ended June 2025. The sales figure stood at Rs. 11169.30 millions during the year-ago period.The company almost doubled its revenue to Rs. 1579.40 millions  from Rs. 287.80 millions in the quarter ended June 2025.Operating profit surged to 3489.00 millions from the corresponding previous quarter of 1706.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 14327.50 11169.30 28.28 14327.50 11169.30 28.28 52169.80 48123.90 8.41
Other Income 215.20 93.00 131.40 215.20 93.00 131.40 1004.70 474.20 111.87
PBIDT 3489.00 1706.90 104.41 3489.00 1706.90 104.41 10448.00 7973.00 31.04
Interest 438.90 408.90 7.34 438.90 408.90 7.34 1822.00 1508.20 20.81
PBDT 3050.10 1298.00 134.98 3050.10 1298.00 134.98 8626.00 6464.80 33.43
Depreciation 935.70 910.00 2.82 935.70 910.00 2.82 3587.90 3450.10 3.99
PBT 2114.40 388.00 444.95 2114.40 388.00 444.95 5038.10 3014.70 67.12
TAX 535.00 100.20 433.93 535.00 100.20 433.93 1234.20 777.70 58.70
Deferred Tax -61.60 -72.40 -14.92 -61.60 -72.40 -14.92 -304.20 -101.70 199.12
PAT 1579.40 287.80 448.78 1579.40 287.80 448.78 3803.90 2237.00 70.04
Equity 1079.60 1078.30 0.12 1079.60 1078.30 0.12 1078.50 1077.90 0.06
PBIDTM(%) 24.35 15.28 59.35 24.35 15.28 59.35 20.03 16.57 20.88

Laurus Labs Share Price

1135.00 5.40 (0.48%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×